*** novogen update: cure for all cancer ***, page-4

It's interesting to see Novogen didn't make an announcement even though some very market sensitive news was released.

I would have thought that mentioning the 20-30% success rate (which is great in such sick patients) and the fact that more trials are about to start, and that they have found a new compound on pancreatic cancer is all market sensitive?

I'm sure most NRT owners don't know any of this and might infact have a sell order in the market just because they don't know that the drug works yet.

From Dr Rutherford's (Yale university) mouth... "that's phenomenal" when referring to the 20-30% success rate.

Cheers,
Munch.